Glipizide Online

How and where to order Glipizide (Glucotrol and Glucotrol XL) 5 mg, 10 mg tablets or capsules online on the Advantage Home Telehealth, Inc. website:

Shop:	DFH PHARMACY - 10% discount coupon DFHDCC
Sellers:	GLIPIZIDE STORES
Prices:	from $0.22 per pill
Forms:	tablets 5 mg, 10 mg
Quantity:	30-360 pills
Type:	Glipizide brand, Glucotrol generic, Glucotrol XL generic
Payment:	Visa, Mastercard, AmEx, Cryptocurrencies
Delivery:	Regular and express mail service
Shipping:	Worldwide, including USA, UK, Europe, Canada, Australia

Indications and usage:

Glucotrol and Glucotrol XL (Glipizide) tablets are a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Limitations of use: not for treatment of type 1 diabetes or diabetic ketoacidosis.

Dosage and administration:

Recommended starting dose of glipizide is 5 mg once daily. Dose adjustment can be made based on the patient's glycemic control. Maximum recommended dose is 20 mg once daily.

Administer with breakfast or the first meal of the day.

For combination therapy with other blood-glucose-lowering agents, initiate the agent at the lowest recommended dose, and observe pati ents for hypoglycemia.

Dosage forms and strengt:

Glucotrol (Glipizide) tablets: 5 mg, 10 mg.

Glucotrol XL (Glipizide) extended release tablets: 2.5 mg, 5 mg, 10 mg.

Contraindications:

Known hypersensitivity to glipizide or any of the product's ingredients.

Hypersensitivity to sulfonamide derivatives.

Warnings and precautions:

Hypoglycemia: may be severe. Ensure proper patient selection, dosing, and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications.

Hemolytic anemia: can occur if glucose 6-phosphate dehydrogenase (G6PD) deficient. Consider a non-sulfonylurea alternative.

Potential increased risk of cardiovascular mortality with sulfonylureas: inform patient of risks, benefits and treatment alternatives.

Macrovascular outcomes: no clinical studies have established conclusive evidence of macrovascular risk reduction with glipizide or any other anti-diabetic drug.

Adverse reactions, side effects:

Most common adverse reactions of glipizide are dizziness, diarrhea, nervousness, tremor, hypoglycemia and flatulence.

To report suspected side effects of Glucotrol or Glucotrol XL (Glipizide) tablets contact Pfizer pharmaceutical company, or your local FDA.

Overdosage:

Overdosage of sulfonylureas including Glipizide (Glucotrol and Glucotrol XL) can produce severe hypoglycemia. Mild hypoglycemic symptoms without loss of consciousness or neurologic findings should be treated with oral glucose. Severe hypoglycemic rea ctions with coma, seizure, or other neurological impairment are medical emergencies requiring immediate treatment. The patient should be trea ted with gluca gon or intra venous glucose. Patients should be closely monitored for a minimum of 24 to 48 hours since hypoglycemia may recur a fter a pparent clinical recovery. Clearance of glipizide from pla sma may be prolonged in persons with liver disease. Because of the extensive protein binding of glipizide, dialysis is unlikely to be of benefit.

Drug interactions:

Certain medications may affect glucose metabolism, requiring Glucotrol XL dose adjustment and close monitoring of blood glucose.

Miconazole: monitor patients closely. Severe hypoglycemia can occur when Glucotrol and oral miconazole are used concomitantly.

Fluconazole: monitor patients closely. An increase in Glucotrol AUC was seen after fluconazole administration.

Colesevelam: Glucotrol XL should be administered at least 4 hours prior to colesevelam.

Use in specific populations:

Pregnancy

Sulfonylureas should be discontinued at least two weeks before expected delivery.

Lactation

Breastfed infants of lactating women using Glucotrol tablets should be monitored for symptoms of hypoglycemia.

Pediatric use

Safety and effectiveness in children have not been established.

Geriatric, hepatically impaired patients

At risk for hypoglycemia with glipizide pills. Use caution in dose selection and titration, and monitor closely.

Patient counseling information:

Advise the patient to read the FDA approved patient labeling.

Inform patients of the potential adverse reactions of Glucotrol and Glucotrol XL including hypoglycemia. Explain the risks of hypoglycemia, its symptoms and treatment, and conditions that predispose to its development to patients and responsible family members. Also inform patients about the importance of adhering to dietary instructions, of a regular exercise program, and of regular testing of glycemic control.

Inform patients that glipizide tablets should be swallowed whole. Inform patients that they should not chew, divide or crush tablets and they may occasionally notice in their stool something that looks like a tablet. In the Glucotrol XL tablet, the medication is contained within a non-dissolvable shell that has been specially designed to slowly release the drug so the body can absorb it.

Pregnancy

Advise females of reproductive potential to inform their prescriber of a known or suspected pregnancy.

Lactation

Advise breastfeeding women taking Glipizide (Glucotrol, Glucotrol XL) pills to monitor breastfed infants for signs of hypoglycemia (e.g., jitters, cyanosis, hypothermia, excessive sleepiness, poor feeding, seizures).

Where to buy glipizide online:

To purchase Glucotrol and Glucotrol XL (Glipizide) 5 mg, 10 mg tablets from reliable online pharmacies and drugstores at low prices please use resources described above on this webpage.

Here is a list of popular medications containing glipizide as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

Trade name of the drug	Pharmaceutical forms and doses	Companies
Glucotrol	Tablets; Oral; 2.5 mg, 5 mg, 10 mg	Pfizer Jenburkt Pharmaceuticals Roerig
Glucotrol XL	Tablets, Extended Release; Oral; 2.5 mg, 5 mg, 10 mg	Pfizer DCH Auriga Roerig
Glynase	Tablets; Oral; 1.5 mg, 2.5 mg, 5 mg	USV Condor Healthcare
Minidiab	Tablets; Oral; 2.5 mg, 5 mg	Pfizer Dexo Laboratoire Flex Pharma Laphal Industries Primal Chemical Zentiva